Evaluation and Optimization of NCD Screening and Management Tool - A Three-arm Quasi-experimental study in selected Talukas of Karnataka including Digital Health Needs Finding Study (IEC No. 237/2019)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2021 - 2023
Project Lead
Authors
Dr. Tony Raj, Dr. Satchit Balsari,
Project Status
completed
Project Type
Original